Home » AstraZeneca Acquires Chinese Generics Maker, Guangdong BeiKang Pharma
AstraZeneca Acquires Chinese Generics Maker, Guangdong BeiKang Pharma
AstraZeneca announced it has entered into an agreement to acquire Guangdong BeiKang Pharmaceutical, a privately-owned generics manufacturing company, based in Conghua City, Guangdong province, China.
Asian Scientist
Asian Scientist
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May